Enlivex Therapeutics Ltd Net Asset Quality Index
Enlivex Therapeutics Ltd net asset quality index. Enlivex Therapeutics Ltd (ENLV) has a Net Asset Quality Index of 83.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA20.94 Million minus total liabilities of ILA3.46 Million yields net assets of ILA17.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore Enlivex Therapeutics Ltd (ENLV) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Enlivex Therapeutics Ltd (2012–2024)
Net asset quality index of Enlivex Therapeutics Ltd from 2012 to 2024. This chart shows how Enlivex Therapeutics Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 83.5%, representing net assets of ILA17.48 Million against total assets of ILA20.94 Million ILA. See ENLV book value for net asset value and shareholders' equity analysis.
Enlivex Therapeutics Ltd Net Asset Quality Index by Year (2012–2024)
Enlivex Therapeutics Ltd net asset quality index by year from 2012 to 2024. The table below presents the year-by-year Net Asset Quality Index for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Enlivex Therapeutics Ltd.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.2% | ILA23.59 Million | ILA27.69 Million | ILA4.10 Million | ▲ +3.5 pp |
| 2023 | 81.7% | ILA30.08 Million | ILA36.83 Million | ILA6.75 Million | ▼ -2.4 pp |
| 2022 | 84.0% | ILA56.84 Million | ILA67.64 Million | ILA10.80 Million | ▼ -5.3 pp |
| 2021 | 89.4% | ILA85.04 Million | ILA95.15 Million | ILA10.11 Million | ▲ +1.4 pp |
| 2020 | 87.9% | ILA35.49 Million | ILA40.36 Million | ILA4.87 Million | ▲ +23.7 pp |
| 2019 | 64.2% | ILA11.28 Million | ILA17.56 Million | ILA6.28 Million | ▼ -23.7 pp |
| 2018 | 88.0% | ILA9.71 Million | ILA11.03 Million | ILA1.33 Million | ▲ +0.7 pp |
| 2017 | 87.3% | ILA3.16 Million | ILA3.62 Million | ILA460.00K | ▲ +5.5 pp |
| 2016 | 81.8% | ILA8.70 Million | ILA10.63 Million | ILA1.93 Million | ▼ -5.6 pp |
| 2015 | 87.4% | ILA17.93 Million | ILA20.52 Million | ILA2.58 Million | ▼ -5.7 pp |
| 2014 | 93.1% | ILA30.67 Million | ILA32.95 Million | ILA2.28 Million | ▼ -4.6 pp |
| 2013 | 97.7% | ILA5.55 Million | ILA5.69 Million | ILA131.00K | ▲ +49.6 pp |
| 2012 | 48.1% | ILA75.00K | ILA156.00K | ILA81.00K | — |